ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia

Haematologica

Volumn 90, Issue 8, 2005, Pages 1078-1088

  Corcoran, Martin ^a,b   Parker, Anton ^a   Orchard, Jenny ^a   Davis, Zadie ^a   Wirtz, Michaela ^a,c   Schmitz, Oliver J ^a,c   Oscier, David ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

CLL; Methylation; ZAP 70

Indexed keywords

GENOMIC DNA; PROTEIN KINASE ZAP 70;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER SURVIVAL; CAPILLARY ELECTROPHORESIS; CHRONIC LYMPHATIC LEUKEMIA; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; SOUTHERN BLOTTING; T LYMPHOCYTE SUBPOPULATION;

5' UNTRANSLATED REGIONS; CONSERVED SEQUENCE; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; HUMANS; INTRONS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC; REFERENCE VALUES; RESTRICTION MAPPING; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 24944464149     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, et al. Multivariate analysis of prognostic factors in CLL; clinical stage, IgVH gene mutational status and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177-84.
2. Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, et al. V (H) mutation status, CD38 expression level, genomic aberrations and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-6.
3. Tobin G, Soderberg O, Thunberg U, Rosenquist R. V(H)3-21 gene usage in chronic lymphocytic leukemia-characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma 2004;45:221-8.
4. Hamblin T, Davis Z, Gardiner A, Oscier D, Stevenson F. Unmutated IgVH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-54.
5. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-7.
6. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639-47.
7. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglublin genes, inferior clinical outcome and distinct gene expression profile. Blood 2003;101:4944-51.
8. Durig J, Nuckel H, Cremer M, Fuhrer A, Halfmeyer K, Fandrey J, et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 2003;17:2426-34.
9. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;18:1764-75.
10. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363:105-11.
11. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, et al. ZAP-70 compared with immunoglobulin heavy-chain mutation status as predictors of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893-901.
12. Chan AC, Irving BA, Fraser JD, Weiss A. The z chain is associated with a tryrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci USA 1991;88:9166-70.
13. Vivier E, da Silva AJ, Ackerly M, Levine H, Rudd CE, Anderson P. Association of 70-kDa tyrosine phosphoprotein with the CD16: zg complex expressed in human natural killer cells. Eur J Immunol 1993;23:1872-6.
14. Ticchioni M, Charvet C, Noraz N, Lamy L, Steinberg M, Bernard A, et al. ZAP-70 is required for CXCL12 mediated T-cell transendothelial migration. Blood 2002;99:3111-8.
15. Elder ME, Hope TJ, Parslow TG, Umetsu DT, Wara DW, Cowan MJ. Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency. Cell Immunol 1995;165:110-7.
16. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003;426:454-60.
17. Mostoslavsky R, Alt FW, Bassing CH. Chromatin dynamics and locus accessibility in the immune system. Nature Immunology 2003;4:603-6.
18. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54.
19. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:25324.
20. Clark S, Harrison J, Paul C, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 2004;22:2990-7.
21. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;11:1427-31.
22. Wirtz M, Stach D, Kliem HC, Wiessler M, Schmitz OJ. Determination of the DNA methylation level in tumor cells by capillary electrophoresis and laser-induced fluorescence detection. Electrophoresis 2004;25:839-45.
23. Schweighoffer E, Vanes L, Mathiot A, Nakamura T, Tybulewicz VLJ. Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. Immunity 2003;18:523-33.
24. Meade J, Tybulewicz VLJ, Tuner M. The tyrosine kinase Syk is required for light chain isotype exclusion but dispensable for the negative selection of B cells. Eur J Immunol 2004;34:1102-10.
25. Crespo M, Villamor N, Bosch F, Giné E, Campo E, Montserrat E. ZAP-70 is expressed in normal B cells of immature phenotype and in some B acute lymphoblastic leukemias. Hematol J 2004;Suppl2:S19.
26. Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841-94.
27. Nolz JC, Tschumper RC, Pittner BT, Darce JR, Kay NE, Jelinek DE. ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype. Leukemia 2005;31:[Epub ahead of print]
28. Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004;64:2424-33.
29. Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E, et al. Aberrant DNA methylation of p57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood 2002;100:2572-7.
30. Stach D, Schmitz OJ, Stilgenbauer S, Benner A, Dohner H, Wiessler M, et al. Capillary electrophoretic analysis of genomic DNA methylation levels. Nucleic Acids Res 2003;31:E2.
31. de Capoa A, Grappelli C, Febbo FR, Spano A, Niveleau A, Cafolla A, et al. Methylation levels of normal and chronic lymphocytic leukemia B lymphocytes: computer-assisted quantitative analysis of anti-5 methylcytosine antibody binding to individual nuclei. Cytometry 1999;36:157-9.
32. Wahlfors J, Hiltunen H, Heinonen K, Hamalainen E, Alhonen L, Janne J. Genomic hypomethylation in human chronic lymphocytic leukemia. Blood 1992;80:2074-80.
33. Melki JR, Vincent PC, Brown RD, Clark SJ. Hypermethylation of E-cadherin in leukemia. Blood 2000;95:3208-13.
34. Crossen PE, Morrison MJ. Hypermethylation of the M27, (DXS255) locus in chronic B-cell leukemia. Br J Haematol 1998;100:191-3.
35. Kanada M, Delia D, Aiello A, Stadtmauer E, Reed J C. Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukaemia. Blood 1993;82:1820-8.
36. Lipsanen V, Leinonen P, Alhonen L, Janne J. Hypomethylation of ornithine decarboxylase gene and erb-Al oncogene in human chronic lymphatic leukemia. Blood 1988;72:2042-4.
37. Bechter OE, Eisterer W, Dlaska M, Ruhr T, Thaler J. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia, Exp Hematol 2002;30:26-33.
38. Yuille MR, Condie A, Stone EM, Wilsher J, Bradshaw PS, Brooks L, et al. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Genes Chromosomes Cancer 2001;30:336-41.
39. Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Carcinogenesis 2004;25:693-701.
40. Pang RT, Lee LT, Ng SS, Yung WH, Chow BK. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. Mol Endocrinol 2004;18:471-83.
41. Georgopoulos S, Kan HY, Reardon-Alulis C, Zannis V. The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice. Nucleic Acids Res 2000;28:4919-29.
42. Clark SJ, Harrison J, Molloy PL. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene. 1997;195:67-71.
43. Sup SJ, Domiati-Saad R, Kelley TW, Steinle R, Zhao X, Hsi ED. ZAP-70 expression in B-cell hematologic malignancy is not limited to CLL/SLL. Am J Clin Pathol 2004;122:582-7.
44. Carreras J, Villamor N, Colomo L, Moreno C, Ramon y Cajal S, Crespo M, et al. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. J Pathol 2005;205:507-13.
45. Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002;100:4609-14.
46. Chen L, Apgar J, Huynh L, Dicker F, Giago-McGahan T, Rassenti L, et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia Blood 2005;105:2036-41.
47. Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW, et al. Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 1999;94:1401-8.
48. Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME, et al. Depsipeptide (FR901228) induces histone acetylatiuon and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8 - mediated apoptosis and down-regulation of c-FLIP protein. Blood 2003;102:652-8.